Inhibrx financial statements

Name: Quantus Signal — KR/US technical signal dataset
License: https://www.quantus.kr/signal/terms

인히브릭스 바이오사이언시스NASDAQ:INBX · Nasdaq · Healthcare

$94.56-2.51%

2026-10-05 close · prelim

Inhibrx's published financial data is dated 2026-10-04. 2024 revenue was $0M. 2024 operating profit was $1.69B.

Reported results

Quantus Signal · live data · not investment advice · Privacy Policy